Literature DB >> 15309099

Similarities in Mechanisms and Treatments for Epileptic and Nonepileptic Myoclonus.

Gregory L. Krauss1, Gregory C. Mathews.   

Abstract

Myoclonus is a disordered movement that may be an ictal phenomenon or may be due to various injuries in brain and spinal cord motor structures. Many epileptic and nonepileptic myoclonic conditions are associated with abnormalities in inhibitory neurotransmission. gamma-Aminobutyric acid type A (GABA(A))-receptor antagonists may trigger myoclonus. Several antiepilepsy drugs (AEDs) effective against myoclonic seizures [valproic acid (VPA), clonazepam (CZP), levetiracetam (LEV)] enhance GABAergic neurotransmission and improve myoclonic movement disorders. Together these associations suggest links between episodic disorders involving synchronous cortical discharges (seizures) and hyperkinetic movement disorders.

Entities:  

Year:  2003        PMID： 15309099      PMCID： PMC321155          DOI： 10.1111/j.1535-7597.2003.03107.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.872


  20 in total

Review 1.  Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor.

Authors:  P Brown; P D Thompson
Journal:  Mov Disord       Date:  2001-07       Impact factor: 10.338

2.  The clinical challenge of posthypoxic myoclonus.

Authors:  Steven J Frucht
Journal:  Adv Neurol       Date:  2002

3.  Amelioration of spinal myoclonus with levetiracetam.

Authors:  S C Keswani; E H Kossoff; G L Krauss; C Hagerty
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

4.  Early and late intracortical inhibition in juvenile myoclonic epilepsy.

Authors:  P Manganotti; L G Bongiovanni; G Zanette; A Fiaschi
Journal:  Epilepsia       Date:  2000-09       Impact factor: 5.864

5.  Coherent cortical and muscle discharge in cortical myoclonus.

Authors:  P Brown; S F Farmer; D M Halliday; J Marsden; J R Rosenberg
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

Review 6.  Electrophysiological studies of myoclonus.

Authors:  H Shibasaki
Journal:  Muscle Nerve       Date:  2000-03       Impact factor: 3.217

Review 7.  Involvement of GABA(A) receptors in myoclonus.

Authors:  R R Matsumoto; D D Truong; K D Nguyen; A T Dang; T T Hoang; P Q Vo; P Sandroni
Journal:  Mov Disord       Date:  2000       Impact factor: 10.338

Review 8.  Myoclonic-astatic epilepsy of early childhood--clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome.

Authors:  H Oguni; Y Fukuyama; T Tanaka; K Hayashi; M Funatsuka; M Sakauchi; S Shirakawa; M Osawa
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

9.  Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.

Authors:  G L Krauss; A Bergin; R E Kramer; Y W Cho; S G Reich
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

10.  Antimyoclonic effect of levetiracetam.

Authors:  P Genton; P Gélisse
Journal:  Epileptic Disord       Date:  2000-12       Impact factor: 1.819
View more
  9 in total

Review 1.  [Myoclonus].

Authors:  H M Meinck
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

2.  Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin.

Authors:  Bjørnar Hassel; Erik Taubøll; Renee Shaw; Leif Gjerstad; Ray Dingledine
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

3.  Clinical and Electrophysiological Findings in Two Siblings with Familial Hyperekplexia.

Authors:  Yeşim Gülen Abanoz; Yasin Abanoz; Ayşegül Gündüz; Nurten Uzun; Meral E Kiziltan
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

4.  Palmitoyl protein thioesterase-1 deficiency impairs synaptic vesicle recycling at nerve terminals, contributing to neuropathology in humans and mice.

Authors:  Sung-Jo Kim; Zhongjian Zhang; Chinmoy Sarkar; Pei-Chih Tsai; Yi-Ching Lee; Louis Dye; Anil B Mukherjee
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

5.  Use of antiepileptic drugs for hyperkinetic movement disorders.

Authors:  A Siniscalchi; L Gallelli; G De Sarro
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

6.  Effect of Fentanyl and Nalbuphine for Prevention of Etomidate-Induced Myoclonus.

Authors:  Megha Bisht; Abhimanyu Singh Pokhriyal; Gurjeet Khurana; Jagdish P Sharma
Journal:  Anesth Essays Res       Date:  2019 Jan-Mar

7.  Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management.

Authors:  Antonio Siniscalchi; Luca Gallelli; Angelo Labate; Giovanni Malferrari; Caterina Palleria; Giovambattista De Sarro
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

8.  Overexpression of BDNF increases excitability of the lumbar spinal network and leads to robust early locomotor recovery in completely spinalized rats.

Authors:  Ewelina Ziemlińska; Sebastian Kügler; Melitta Schachner; Iwona Wewiór; Julita Czarkowska-Bauch; Małgorzata Skup
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

9.  Cortical Subarachnoid Hemorrhage Presenting with Hemibody Dystonic Myoclonus: An Illustrative Case.

Authors:  Hyunjin Ju; Eun Ji Lee; Mina Lee; Kayeong Im; Kyum-Yil Kwon
Journal:  J Mov Disord       Date:  2021-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.